Fang J, Wu S, Zhao H, Zhou C, Xue L, Lei Z
J Cardiovasc Transl Res. 2025; .
PMID: 40032789
DOI: 10.1007/s12265-025-10600-7.
Chamorro-Jorganes A, Profitos-Peleja N, Recasens-Zorzo C, Valero J, Reyes-Garau D, Magnano L
Neoplasia. 2025; 61:101131.
PMID: 39914169
PMC: 11847303.
DOI: 10.1016/j.neo.2025.101131.
Bondhus L, Nava A, Liu I, Arboleda V
Epigenetics Chromatin. 2025; 18(1):8.
PMID: 39893491
PMC: 11786378.
DOI: 10.1186/s13072-025-00571-z.
Bousquet L, Fainsod S, Decelle J, Murik O, Chevalier F, Gallet B
New Phytol. 2024; 245(5):1969-1984.
PMID: 39721990
PMC: 11798906.
DOI: 10.1111/nph.20360.
Kurani H, Kurani H, Slingerland J
Cancer Res. 2024; 85(5):838-847.
PMID: 39700409
PMC: 11873724.
DOI: 10.1158/0008-5472.CAN-24-3304.
ChIP-DIP maps binding of hundreds of proteins to DNA simultaneously and identifies diverse gene regulatory elements.
Perez A, Goronzy I, Blanco M, Yeh B, Guo J, Lopes C
Nat Genet. 2024; 56(12):2827-2841.
PMID: 39587360
DOI: 10.1038/s41588-024-02000-5.
Active enhancers: recent research advances and insights into disease.
Zhang J, Wang Q, Liu J, Duan Y, Liu Z, Zhang Z
Biol Direct. 2024; 19(1):112.
PMID: 39533395
PMC: 11556110.
DOI: 10.1186/s13062-024-00559-x.
Chromatin remodeller Chd7 is developmentally regulated in the neural crest by tissue-specific transcription factors.
Williams R, Taylor G, Ling I, Candido-Ferreira I, Fountain D, Mayes S
PLoS Biol. 2024; 22(10):e3002786.
PMID: 39418292
PMC: 11521297.
DOI: 10.1371/journal.pbio.3002786.
An RNA-centric view of transcription and genome organization.
Henninger J, Young R
Mol Cell. 2024; 84(19):3627-3643.
PMID: 39366351
PMC: 11495847.
DOI: 10.1016/j.molcel.2024.08.021.
Mucosa-like differentiation of head and neck cancer cells is inducible and drives the epigenetic loss of cell malignancy.
Oppel F, Gendreizig S, Martinez-Ruiz L, Florido J, Lopez-Rodriguez A, Pabla H
Cell Death Dis. 2024; 15(10):724.
PMID: 39358322
PMC: 11446932.
DOI: 10.1038/s41419-024-07065-y.
WDR77 in Pan-Cancer: Revealing expression patterns, genetic insights, and functional roles across diverse tumor types, with a spotlight on colorectal cancer.
Wang Y, Wu Q, Liu J, Wang X, Xie J, Fu X
Transl Oncol. 2024; 49:102089.
PMID: 39182364
PMC: 11388772.
DOI: 10.1016/j.tranon.2024.102089.
Spatial 3D genome organization controls the activity of bivalent chromatin during human neurogenesis.
Ahanger S, Zhang C, Semenza E, Gil E, Cole M, Wang L
bioRxiv. 2024; .
PMID: 39131314
PMC: 11312588.
DOI: 10.1101/2024.08.01.606248.
The impact of histone lactylation on the tumor microenvironment and metabolic pathways and its potential in cancer therapy.
Zhou J, Ma X, Liu X, Liu Y, Fu J, Qi Y
Genes Genomics. 2024; 46(9):991-1011.
PMID: 39127851
DOI: 10.1007/s13258-024-01554-2.
Assessing next-generation sequencing-based computational methods for predicting transcriptional regulators with query gene sets.
Lu Z, Xiao X, Zheng Q, Wang X, Xu L
Brief Bioinform. 2024; 25(5.
PMID: 39082650
PMC: 11289684.
DOI: 10.1093/bib/bbae366.
Epigenetic Regulation of Mammalian Cardiomyocyte Development.
Mensah I, Gowher H
Epigenomes. 2024; 8(3).
PMID: 39051183
PMC: 11270418.
DOI: 10.3390/epigenomes8030025.
An optimized and robust workflow for quantifying the canonical histone ubiquitination marks H2AK119ub and H2BK120ub by LC-MS/MS.
Lopes M, Lund P, Garcia B
bioRxiv. 2024; .
PMID: 38915586
PMC: 11195131.
DOI: 10.1101/2024.06.11.596744.
Chromatin profiling identifies putative dual roles for H3K27me3 in regulating transposons and cell type-specific genes in choanoflagellates.
Gahan J, Helfrich L, Wetzel L, Bhanu N, Yuan Z, Garcia B
bioRxiv. 2024; .
PMID: 38854040
PMC: 11160669.
DOI: 10.1101/2024.05.28.596151.
Disease related changes in ATAC-seq of iPSC-derived motor neuron lines from ALS patients and controls.
Tsitkov S, Valentine K, Kozareva V, Donde A, Frank A, Lei S
Nat Commun. 2024; 15(1):3606.
PMID: 38697975
PMC: 11066062.
DOI: 10.1038/s41467-024-47758-8.
Chromatin modifiers in human disease: from functional roles to regulatory mechanisms.
Nie Y, Song C, Huang H, Mao S, Ding K, Tang H
Mol Biomed. 2024; 5(1):12.
PMID: 38584203
PMC: 10999406.
DOI: 10.1186/s43556-024-00175-1.
Redistribution of mutation risk in cancer.
Hu X, De S
Nat Cancer. 2024; 5(2):216-217.
PMID: 38418776
PMC: 11272390.
DOI: 10.1038/s43018-024-00728-x.